Treatment results showed that Rag2−/− tumors were markedly reduced by infusing Ogr1−/−-CD8+ T cells, whereas the difference in tumor weight between the treatments of infused Ogr1−/−-CD4+ T cells and infused WT-CD8+ T cells did not significantly change (Fig. 6B, C). The gene discussed is CD8A; the disease is neoplasm.